Detection of 18F-FDG PET/CT occult lesions with 18F-DCFPyL PET/CT in a patient with metastatic renal cell carcinoma

Clinical Nuclear Medicine

Volumn 41, Issue 1, 2016, Pages 83-85

  Rowe, Steven P ^a   Gorin, Michael A ^a   Hammers, Hans J ^b   Pomper, Martin G ^a   Allaf, Mohammad E ^a   Javadi, Mehrbod Som ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

metastatic renal cell carcinoma; PET CT; prostate specific membrane antigen (PSMA)

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PROSTATE SPECIFIC MEMBRANE ANTIGEN; TRACER; 2-(3-(1-CARBOXY-5-((6-FLUOROPYRIDINE-3-CARBONYL)AMINO)PENTYL)UREIDO)PENTANEDIOIC ACID; LYSINE; RADIOPHARMACEUTICAL AGENT; UREA;

ADULT; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CLEAR CELL CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; HUMERUS; ILIAC BONE; KIDNEY METASTASIS; MALE; MIDDLE AGED; SKELETON; ANALOGS AND DERIVATIVES; DIAGNOSTIC IMAGING; KIDNEY CARCINOMA; METASTASIS; MULTIMODAL IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; X-RAY COMPUTED TOMOGRAPHY;

CARCINOMA, RENAL CELL; FLUORODEOXYGLUCOSE F18; HUMANS; LYSINE; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM METASTASIS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; UREA;

EID: 84951907767     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000995     Document Type: Article

References (8)

1. Cho SY, Gage KL, Mease RC, Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer. J Nucl Med. 2012; 53: 1883-1891
2. Eiber M, Maurer T, Souvatzoglou M, Evaluation of hybrid Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 2015; 56: 668-674
3. Szabo Z, Mena E, Rowe SP, Initial evaluation of [(18)F]DCFPyL for prostate-specific membrane antigen (PSMA)-Targeted PET imaging of prostate cancer. Mol Imaging Biol. 2015; 17: 565-574. Epub ahead of print
4. Rowe SP, Gage KL, Faraj SF, 18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer. J Nucl Med. 2015; 56: 1003-1010. Epub ahead of print
5. Demirci E, Ocak M, Kabasakal L, (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2014; 41: 1461-1462
6. Sathekge M, Modiselle M, Vorster M, (68)Ga-PSMA imaging of metastatic breast cancer. Eur J Nucl Med Mol Imaging. 2015; 42: 1482-1483
7. Chang SS, O'Keefe DS, Bacich DJ, Prostate-specific membrane antigen is produced in tumor-Associated neovasculature. Clin Cancer Res. 1999; 5: 2674-2681
8. Baccala A, Sercia L, Li J, Expression of prostate-specific membrane antigen in tumor-Associated neovasculature of renal neoplasms. Urology. 2007; 70: 385-390